SKI Market

A+| A| A-|

Indian Indices

Sensex

76,488.96 1,073.61
( 1.42%)

Global Indices

Nasdaq

50,600.73 294.06
(0.58%)

Dow Jones

7,493.73 27.01
(0.36%)

Hang Seng

65,182.04 1,842.97
(2.91%)

Nikkei 225

10,474.02 30.55
(0.29%)

Forex

USD-INR

96.29 -0.42
(-0.43%)

EUR-INR

111.82 -0.44
(-0.39%)

GBP-INR

129.28 -0.40
(-0.31%)

JPY-INR

0.61 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

375.7898972

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

33.88

109098.01

EPS(TTM)

Face Value()

Div & Yield %

38.58

0.61

Back

Steadfast Corporation reports standalone net profit of Rs 0.09 crore in the December 2025 quarter

Feb 15,2026

Net profit of Steadfast Corporation reported to Rs 0.09 crore in the quarter ended December 2025 as against net loss of Rs 0.01 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 as against Rs 0.08 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0	0.08	-100
OPM %	0	-150.00	-
PBDT	0.09	0	0
PBT	0.09	-0.01	LP
NP	0.09	-0.01	LP

76,488.96 1,073.61 ( 1.42%)

50,600.73 294.06 (0.58%)

7,493.73 27.01 (0.36%)

65,182.04 1,842.97 (2.91%)

10,474.02 30.55 (0.29%)

96.29 -0.42 (-0.43%)

111.82 -0.44 (-0.39%)

129.28 -0.40 (-0.31%)

0.61 0.00 (-0.48%)